Leeds lecturer receives top honour from American College of Rheumatology
Dr Philip Helliwell has been made a Master of the American College of Rheumatology (ACR), one of the highest honours that the ACR can bestow.
The title of Master is conferred on ACR members who have made outstanding contributions to the field of rheumatology through scholarly achievement and/or service to their patients, students, and the rheumatology profession. Masters have devoted their careers to furthering rheumatology research and improving clinical standards in the treatment of rheumatic diseases.
“It’s an honor to be recognized for my commitment to advancing the health of patients with rheumatic diseases,” said Dr. Helliwell. “I am truly humbled to receive this designation, the first rheumatologist from Leeds to be so honoured, and join the ranks of many distinguished rheumatologists.”
ACR Masters must be highly accomplished individuals. Evidence of their achievements can come from many types of endeavors and honours, such as research, education, health care initiatives, and administrative positions.
Dr Helliwell is a rheumatologist and researcher with a primary interest in psoriatic arthritis. He has worked in this field for over 30 years and has contributed substantially to knowledge of the clinical manifestations of psoriatic arthritis, classification criteria, outcome measurement, and treatment strategies.
He has been chief investigator on two major international collaborative studies and chief investigator for the first strategy trial in psoriatic arthritis.
His clinical duties span two major teaching hospital trusts (Leeds and Bradford).
Dr Helliwell is co-founder and the current President of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) and co-founder of the FASTER group at the University of Leeds and co-lead for the Bradford Diploma in Rheumatology and Musculoskeletal Medicine.
Posted in: University news